{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:28:04Z","timestamp":1789712884519,"version":"4.0.1"},"reference-count":18,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1136\/jnnp-2014-308153","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T21:49:02Z","timestamp":1418766542000},"page":"1143-1149","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Modelling the natural history of Huntington's disease progression"],"prefix":"10.1136","volume":"86","author":[{"given":"W L","family":"Kuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S L","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,12,16]]},"reference":[{"key":"key-10.1136\/jnnp-2014-308153-1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1749-6632.2009.04943.x","article-title":"Biomarkers in Huntington's and Parkinson's disease","volume":"1180","author":"O'Keeffe","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.1136\/jnnp-2014-308153-2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI45130","article-title":"Oligonucleotide therapeutic approaches for Huntington disease","volume":"121","author":"Sah","year":"2011","journal-title":"J Clin Invest"},{"key":"key-10.1136\/jnnp-2014-308153-3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1474-4422(12)70064-9","article-title":"Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations","volume":"11","author":"Galpern","year":"2012","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2014-308153-4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2014-308153-5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","article-title":"A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length","volume":"65","author":"Langbehn","year":"2004","journal-title":"Clin Genet"},{"key":"key-10.1136\/jnnp-2014-308153-6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajmg.b.30992","article-title":"CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches","volume":"153B","author":"Langbehn","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"key-10.1136\/jnnp-2014-308153-7","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1172\/JCI69411","article-title":"Metabolic network as a progression biomarker of premanifest Huntington's disease","volume":"123","author":"Tang","year":"2013","journal-title":"J Clin Invest"},{"key":"key-10.1136\/jnnp-2014-308153-8","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s00415-013-7061-5","article-title":"The Addenbrooke's cognitive examination-revised accurately detects cognitive decline in Huntington's disease","volume":"260","author":"Begeti","year":"2013","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2014-308153-9","first-page":"1520","article-title":"Natural history of Huntington's disease","volume":"70","author":"Dorsey","year":"2013","journal-title":"JAMA Neurol"},{"key":"key-10.1136\/jnnp-2014-308153-10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"The Unified Huntington's Disease Rating Scale: reliability and consistency","volume":"11","author":"Huntington study group","year":"1996","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2014-308153-11","first-page":"7","volume-title":"Understand and prediction biological network using linear system identification, in systems and synthetic biology: a systemic approach","author":"Carignano","year":"2012"},{"key":"key-10.1136\/jnnp-2014-308153-12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/mds.870130609","article-title":"Unified Huntington's Disease Rating Scale: a follow up","volume":"13","author":"Siesling","year":"1998","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2014-308153-13","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/mds.21988","article-title":"The relationship between CAG repeat length and clinical progression in Huntington's disease","volume":"23","author":"Ravina","year":"2008","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2014-308153-14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mds.24024","article-title":"Age, CAG repeat length, and clinical progression in Huntington's disease","volume":"27","author":"Rosenblatt","year":"2012","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2014-308153-15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"key-10.1136\/jnnp-2014-308153-16","doi-asserted-by":"crossref","first-page":"e22966","DOI":"10.1371\/journal.pone.0022966","article-title":"Brain-derived neurotrophic factor in patients with Huntington's disease","volume":"6","author":"Zuccato","year":"2011","journal-title":"PLoS ONE"},{"key":"key-10.1136\/jnnp-2014-308153-17","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1172\/JCI64565","article-title":"Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression","volume":"122","author":"Weiss","year":"2012","journal-title":"J Clin Invest"},{"key":"key-10.1136\/jnnp-2014-308153-18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2014-308153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T13:56:15Z","timestamp":1601042175000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2014-308153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,16]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,9,13]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1136\/jnnp-2014-308153"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2014-308153","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,16]]}}}